Manuel Battegay
University Hospital, Basel, Switzerland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Manuel Battegay as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:17 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03630549 · Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in LesothoNiklaus Labhardt · completed · HIV/AIDS · study chair
- N/ANCT03598686 · HOme-based SElf-testiNG - a Cluster Randomized Controlled Trial in Rural Lesotho (HOSENG)Tracy Glass · completed · HIV, HIV/AIDS · study chair
- Ph4NCT02503462 · Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected IndividualsUniversity Hospital, Basel, Switzerland · terminated · AIDS-related Dementia Complex · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:17 UTC. The ranking covers the 200 most relevant of 39 PubMed records, and a shared surname and initials can bring in a namesake. All 39 on PubMed
- 714 citationsRCR 18.3
- 533 citationsRCR 15.0
- 212 citationsRCR 6.2
- 209 citationsRCR 5.9
- A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.J Infect Dis · 2002123 citationsRCR 3.0
- Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.J Infect Dis · 200587 citationsRCR 1.8
- Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.Antivir Ther · 200585 citationsRCR 2.2
- Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.Antivir Ther · 201180 citationsRCR 2.0
- High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts.J Hepatol · 199755 citationsRCR 2.0
- Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.Clin Exp Immunol · 199949 citationsRCR 1.0